Lilly's triple-G drug beats Ozempic in head-to-head study

Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempi…

Continue in Briflio to read, react, comment, and share.